If the campaign is able to restart its signature collecting efforts by early May, “we’ll have 60 days to get this done,” Garrett said. “It’s not an impossibility.”
Some campaigns are exploring other solutions to the signature-gathering problem.
The Arizona campaign recently joined three other ballot initiatives in filing a petition to the Arizona Supreme Court to allow them to use e-signatures. Advocates are looking into whether they can email people to find out if they are willing to sign a petition if it were dropped off outside their front door so they could use their own pens to sign it. The person could then leave the signed petition outside their door to be collected.
Arkansans for Cannabis Reform plans to work with two other campaigns on separate issues to help each other. The idea is to have canvassers for each campaign carry the petitions for all three signature drives. They’re discussing ways to safely collect signatures, such as having people drive up to canvassers to sign a petition while remaining in their cars.
“We’re just going to have to get really creative,” Fults said.
Meanwhile, other recreational legalization campaigns are all but dead, including those in Missouri and Oklahoma. Medical marijuana legalization campaigns in Idaho and North Dakota have both expressed plans to focus their efforts on making the 2022 ballot instead.
Hopes dashed in state legislatures — for now
“Coronavirus is taking up all the oxygen in the room,” said Andrew Freedman, senior vice president at the public affairs firm Forbes Tate Partners. “People are just going to go home when all the essential business is passed.”
States with marijuana bills including Vermont, New Hampshire, New York and Connecticut all shifted their priorities as coronavirus cases surged.
Cuomo was once coordinating legalization efforts in the entire Northeast region and encouraging state lawmakers to include marijuana legalization in New York’s budget.
But even marijuana’s most vocal supporters in the legislature put the issue aside as the state rushed to pass a budget in the epicenter of the outbreak. The bill’s chief sponsors, Assembly Majority Leader Crystal Peoples-Stokes and Sen. Liz Krueger, both Democrats, doubted its chances during budget negotiations.
“In times of crisis, everyone realizes what they actually need to get done and what they don’t,” Krueger said. “I think a huge number of things will fall off the table both because of time and money reasons.”
Some advocates are hoping the crisis bodes well for legalization efforts in the long run, as states face revenue decimated by the crisis.
“[Cannabis businesses] are taxed heavily,” said Richard Acosta, CEO of Subversive Real Estate Acquisition REIT, a cannabis-focused real estate investment operation. “The economic slowdown makes cannabis legalization at the state and federal level more attractive.”
Oklahoma Republican state Rep. Scott Fetgatter recently said he plans to introduce legislation to establish a taxed, regulated recreational marijuana market, arguing it could bring in $100 million per year in revenue and help with a budget crunch expected because of the health crisis.
But until the worst is over, lawmakers likely will be consumed with more urgent matters. Legislative leaders in Connecticut, who had been discussing marijuana legalization matters with Democrat Gov. Ned Lamont, are now working with the governor on a coronavirus stimulus package. The session has been postponed until at least April 13.
A medical marijuana legalization bill was chugging along in Kentucky’s legislature with a 65-30 vote in the Republican-dominated House.
Now, the bill is languishing in the Senate Judiciary Committee as the legislature swerved to deal with the state budget amid the coronavirus crisis.
Even ardent legalization advocates like Jim Higdon, who owns Kentucky-based CBD company Cornbread Hemp, doesn’t think now is the time to debate medical marijuana legalization. His father Jimmy Higdon is a state senator, and Higdon said he is worried that the legislature is still in session.
“I just want him home.”
Paul Demko, Bill Mahoney, Shannon Young and Marie J. French contributed to this report.